Respiratory Muscle Strength as a Predictor of Exacerbations in Patients With Chronic Obstructive Pulmonary Disease
Respirology · 2025
DOI: 10.1111/resp.70003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Respirology, 2025. Verfasst von Yuichiro Furukawa und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Medicine, Graduate School of Medicine, Osaka City University, Osaka, Japan. Hauptthemen laut MEDLINE: Pulmonary Disease, Chronic Obstructive, Respiratory Muscles, Muscle Strength, Muscle Weakness. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: COPD
Abstract (Originalsprache)
Background and Objective Chronic obstructive pulmonary disease (COPD) is closely related to skeletal muscle dysfunction, and the evaluation of respiratory muscle function has recently been recommended. We aimed to investigate the effects of respiratory muscle dysfunction on clinical outcomes.
Methods
We retrospectively reviewed the medical records of patients with COPD whose respiratory muscle strength was measured between June 2015 and December 2021. We then analysed the effects of respiratory muscle strength on moderate‐to‐severe exacerbations after adjusting for confounding factors, including sex, age, forced expiratory volume in 1‐s percent predicted, hand grip strength, and skeletal muscle mass index. We also compared the temporal relationship between respiratory and systemic skeletal muscle dysfunctions.
Results
Respiratory muscle weakness (RMW) was observed in 48.1% (100) of the 208 patients. Low percent predicted maximal inspiratory pressure was an independent risk factor for moderate‐to‐severe exacerbations within 1 year in the Cox regression analysis (adjusted hazard ratio per 1 standard deviation increase, 0.521; 95% confidence interval, 0.317–0.856). Approximately half of the patients already exhibited RMW at the mild systemic skeletal muscle dysfunction, while those with sarcopenia had higher RMW rates. More patients with RMW experienced progressive systemic skeletal muscle dysfunction within 1 year compared to those without RMW.
Conclusion
Lower respiratory muscle strength is associated with an increased risk of exacerbation. Respiratory muscle function could serve as a marker of disease status and early prognosis in COPD. image
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Respiratory Medicine, Graduate School of Medicine, Osaka City University, Osaka, Japan.
- Department of Respiratory Medicine, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan.
ORCID-Profile: Yuichiro Furukawa, Atsushi Miyamoto, Kazuhiro Yamada
Zitieren
APA
Furukawa, Y., Miyamoto, A., Asai, K., Tsutsumi, M., Hirai, K., Ueda, T., Toyokura, E., Nishimura, M., Sato, K., Yamada, K., Watanabe, T., & Kawaguchi, T. (2025). Respiratory Muscle Strength as a Predictor of Exacerbations in Patients With Chronic Obstructive Pulmonary Disease. Respirology. https://doi.org/10.1111/resp.70003
Vancouver
Furukawa Y, Miyamoto A, Asai K, Tsutsumi M, Hirai K, Ueda T, et al. Respiratory Muscle Strength as a Predictor of Exacerbations in Patients With Chronic Obstructive Pulmonary Disease. Respirology. 2025. doi:10.1111/resp.70003
BibTeX
@article{Furukawa2025,
author = {Furukawa, Yuichiro and Miyamoto, Atsushi and Asai, Kazuhisa and Tsutsumi, Masaya and Hirai, Kaho and Ueda, Takahiro and Toyokura, Erika and Nishimura, Misako and Sato, Kanako and Yamada, Kazuhiro and Watanabe, Tetsuya and Kawaguchi, Tomoya},
title = {Respiratory Muscle Strength as a Predictor of Exacerbations in Patients With Chronic Obstructive Pulmonary Disease},
journal = {Respirology},
year = {2025},
doi = {10.1111/resp.70003}
}
EUVIMED